SG11201804384UA - Geometric configurations for gastric residence systems - Google Patents
Geometric configurations for gastric residence systemsInfo
- Publication number
- SG11201804384UA SG11201804384UA SG11201804384UA SG11201804384UA SG11201804384UA SG 11201804384U A SG11201804384U A SG 11201804384UA SG 11201804384U A SG11201804384U A SG 11201804384UA SG 11201804384U A SG11201804384U A SG 11201804384UA SG 11201804384U A SG11201804384U A SG 11201804384UA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- lyndra
- cambridge
- main street
- pct
- Prior art date
Links
- 230000002496 gastric effect Effects 0.000 title abstract 3
- 244000178231 Rosmarinus officinalis Species 0.000 abstract 1
- 230000008520 organization Effects 0.000 abstract 1
- 230000002035 prolonged effect Effects 0.000 abstract 1
- 210000002784 stomach Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0065—Forms with gastric retention, e.g. floating on gastric juice, adhering to gastric mucosa, expanding to prevent passage through the pylorus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/34—Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyesters, polyamino acids, polysiloxanes, polyphosphazines, copolymers of polyalkylene glycol or poloxamers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/46—Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/08—Processes
- C08G18/10—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step
- C08G18/12—Prepolymer processes involving reaction of isocyanates or isothiocyanates with compounds having active hydrogen in a first reaction step using two or more compounds having active hydrogen in the first polymerisation step
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4202—Two or more polyesters of different physical or chemical nature
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/28—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the compounds used containing active hydrogen
- C08G18/40—High-molecular-weight compounds
- C08G18/42—Polycondensates having carboxylic or carbonic ester groups in the main chain
- C08G18/4266—Polycondensates having carboxylic or carbonic ester groups in the main chain prepared from hydroxycarboxylic acids and/or lactones
- C08G18/4269—Lactones
- C08G18/4277—Caprolactone and/or substituted caprolactone
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G18/00—Polymeric products of isocyanates or isothiocyanates
- C08G18/06—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen
- C08G18/70—Polymeric products of isocyanates or isothiocyanates with compounds having active hydrogen characterised by the isocyanates or isothiocyanates used
- C08G18/72—Polyisocyanates or polyisothiocyanates
- C08G18/73—Polyisocyanates or polyisothiocyanates acyclic
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08L—COMPOSITIONS OF MACROMOLECULAR COMPOUNDS
- C08L83/00—Compositions of macromolecular compounds obtained by reactions forming in the main chain of the macromolecule a linkage containing silicon with or without sulfur, nitrogen, oxygen or carbon only; Compositions of derivatives of such polymers
- C08L83/04—Polysiloxanes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M31/00—Devices for introducing or retaining media, e.g. remedies, in cavities of the body
- A61M31/002—Devices for releasing a drug at a continuous and controlled rate for a prolonged period of time
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Anesthesiology (AREA)
- Botany (AREA)
- Medicinal Preparation (AREA)
- Materials For Medical Uses (AREA)
- Surgical Instruments (AREA)
- Medical Preparation Storing Or Oral Administration Devices (AREA)
- Medicines Containing Plant Substances (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562264811P | 2015-12-08 | 2015-12-08 | |
| PCT/US2016/065453 WO2017100367A1 (en) | 2015-12-08 | 2016-12-07 | Geometric configurations for gastric residence systems |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201804384UA true SG11201804384UA (en) | 2018-06-28 |
Family
ID=59013250
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201804384UA SG11201804384UA (en) | 2015-12-08 | 2016-12-07 | Geometric configurations for gastric residence systems |
Country Status (14)
| Country | Link |
|---|---|
| US (2) | US11992552B2 (enExample) |
| EP (2) | EP4302817A3 (enExample) |
| JP (1) | JP7030052B2 (enExample) |
| KR (1) | KR102796240B1 (enExample) |
| CN (2) | CN120827528A (enExample) |
| AU (1) | AU2016366192B2 (enExample) |
| BR (1) | BR112018011636B1 (enExample) |
| CA (1) | CA3007633A1 (enExample) |
| ES (1) | ES2963058T3 (enExample) |
| IL (1) | IL259838B2 (enExample) |
| MX (1) | MX2018006912A (enExample) |
| SG (1) | SG11201804384UA (enExample) |
| WO (1) | WO2017100367A1 (enExample) |
| ZA (1) | ZA202407197B (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DK3155024T4 (da) | 2014-06-11 | 2025-07-21 | Massachusetts Inst Technology | Opholdsstrukturer og relaterede fremgangsmåder |
| US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
| US10953208B2 (en) | 2015-05-01 | 2021-03-23 | Massachusetts Institute Of Technology | Triggerable shape memory induction devices |
| AU2016342374B2 (en) | 2015-10-23 | 2022-08-04 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof |
| US11992552B2 (en) | 2015-12-08 | 2024-05-28 | Lyndra Therapeutics, Inc. | Geometric configurations for gastric residence systems |
| EP3463313A4 (en) | 2016-05-27 | 2019-12-18 | Lyndra, Inc. | MATERIAL ARCHITECTURE FOR STOMACH DWELLING SYSTEMS |
| AU2017336154B2 (en) | 2016-09-30 | 2023-11-09 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained delivery of adamantane-class drugs |
| DK3624887T3 (da) | 2017-05-17 | 2025-05-19 | Massachusetts Inst Technology | Vævforankringsartikler |
| US11541015B2 (en) | 2017-05-17 | 2023-01-03 | Massachusetts Institute Of Technology | Self-righting systems, methods, and related components |
| WO2018227147A1 (en) | 2017-06-09 | 2018-12-13 | Lyndra, Inc. | Gastric residence systems with release rate-modulating films |
| JP7288435B2 (ja) * | 2017-09-20 | 2023-06-07 | リンドラ セラピューティクス， インコーポレイティド | 胃内滞留システムのカプセル封入 |
| EP3716850A1 (en) * | 2017-11-28 | 2020-10-07 | Massachusetts Institute of Technology | Gastric resident electronics |
| EP3793667A1 (en) | 2018-05-17 | 2021-03-24 | Massachusetts Institute of Technology | Systems for electrical stimulation |
| US12142158B2 (en) | 2018-12-03 | 2024-11-12 | Lyndra Therapeutics, Inc. | Stomach simulating device |
| US11771829B2 (en) | 2019-02-01 | 2023-10-03 | Massachusetts Institute Of Technology | Systems and methods for liquid injection |
| EP3941445A4 (en) | 2019-03-20 | 2023-08-02 | Lyndra Therapeutics, Inc. | CAPSULES AND CAPSULE COATINGS FOR GASOLINE DOSAGE FORMS |
| AU2020378100A1 (en) * | 2019-11-08 | 2022-06-02 | Lyndra Therapeutics, Inc. | Polymeric linkers for a gastric residence system |
| AU2020379040A1 (en) * | 2019-11-08 | 2022-06-09 | Lyndra Therapeutics, Inc. | Gastric residence systems having a filament for improved gastric residence |
| WO2021092484A1 (en) * | 2019-11-08 | 2021-05-14 | Lyndra, Inc. | Gastric residence systems having arms with controlled stiffness for improved gastric residence |
| US20220387311A1 (en) * | 2019-11-08 | 2022-12-08 | Lyndra Therapeutics, Inc. | Gastric residence systems for administration of active agents |
| US11541216B2 (en) | 2019-11-21 | 2023-01-03 | Massachusetts Institute Of Technology | Methods for manufacturing tissue interfacing components |
| DE102019132938A1 (de) * | 2019-12-04 | 2021-06-10 | Cortronik GmbH | Verfahren zur Herstellung einer intraluminalen Endoprothese mit einer biodegradierbaren Hülle |
| US11446114B2 (en) * | 2020-01-21 | 2022-09-20 | Med-Genesis, Llc | Biopsy marker with anchoring capabilities |
| EP4188323A1 (en) | 2020-07-29 | 2023-06-07 | The Secant Group, LLC | Shape-guided controlled release and retention with structures including crosslinked poly(glycerol sebacate) |
| CA3216743A1 (en) * | 2021-05-05 | 2022-11-10 | Estelle BEGUIN | Gastric residence systems comprising methadone |
| JP2025518200A (ja) * | 2022-06-03 | 2025-06-12 | ジュニオン ラブズ ピーティーイー． リミテッド | 経口投与用の胃内滞留装置 |
| WO2024031023A2 (en) * | 2022-08-03 | 2024-02-08 | Lyndra Therapeutics, Inc. | Metal cores for gastric residence systems |
| US20240398701A1 (en) * | 2023-06-02 | 2024-12-05 | Lyndra Therapeutics, Inc. | Manufacturing methods for gastric residence systems |
| WO2025042350A1 (en) * | 2023-08-24 | 2025-02-27 | Junion Therapeutics (Xiamen) Co., Ltd. | A gastric residence article for oral administration |
| WO2025153071A1 (en) * | 2024-01-18 | 2025-07-24 | Junion Therapeutics (Xiamen) Co., Ltd. | Gastric residence article for oral administration |
Family Cites Families (155)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1957564A (en) * | 1932-11-23 | 1934-05-08 | Aubra T West | Expanding capsule body |
| US3154461A (en) | 1960-03-07 | 1964-10-27 | Minnesota Mining & Mfg | Matte-finish polymeric film and method of forming the same |
| US3531368A (en) | 1966-01-07 | 1970-09-29 | Toray Industries | Synthetic filaments and the like |
| US3716614A (en) | 1969-05-12 | 1973-02-13 | Toray Industries | Process of manufacturing collagen fiber-like synthetic superfine filament bundles |
| AU449029B2 (en) * | 1969-08-28 | 1974-04-17 | Commonwealth Scientific And Industrial Research Organisation | Device for administration to ruminants |
| JPS5512411B2 (enExample) | 1974-03-12 | 1980-04-02 | ||
| US4304767A (en) | 1980-05-15 | 1981-12-08 | Sri International | Polymers of di- (and higher functionality) ketene acetals and polyols |
| NO155805C (no) | 1981-02-06 | 1987-06-10 | Ucb Sa | Analogifremgangsmaate for fremstilling av terapeutisk virksomme 2-(4-(difenylmethyl)-1-piperazinyl)-eddiksyrer og deres amider og ikke-toksiske salter. |
| US4451260A (en) | 1982-03-26 | 1984-05-29 | Minnesota Mining And Manufacturing Company | Sustained release oral medicinal delivery device |
| US4676507A (en) | 1985-05-06 | 1987-06-30 | Patterson Bruce D | Puzzles forming platonic solids |
| JPS6226215A (ja) | 1985-05-10 | 1987-02-04 | メルク エンド カムパニ− インコ−ポレ−テツド | 一定に制御した時間内胃中に保持できる薬剤移送装置 |
| US4735804A (en) | 1985-05-10 | 1988-04-05 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
| DE3680024D1 (de) * | 1985-05-10 | 1991-08-08 | Merck & Co Inc | Abgabesystem fuer arzneimittel, das waehrend einer kontrollierten zeitspanne im magen zurueckgehalten werden kann. |
| US4767627A (en) * | 1985-05-29 | 1988-08-30 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
| US4758436A (en) | 1985-05-29 | 1988-07-19 | Merck & Co., Inc. | Drug delivery device which can be retained in the stomach for a controlled period of time |
| EP0253554A3 (en) | 1986-07-15 | 1988-07-20 | Pfizer Inc. | Controlled release drug-containing fibers |
| CA1314742C (en) | 1986-12-12 | 1993-03-23 | Hiromu Terada | Optical fiber array |
| IL87710A (en) | 1987-09-18 | 1992-06-21 | Ciba Geigy Ag | Covered floating retard form for controlled release in gastric juice |
| US5002772A (en) | 1988-05-31 | 1991-03-26 | Pfizer Inc. | Gastric retention system for controlled drug release |
| NZ228382A (en) | 1989-03-17 | 1992-08-26 | Carter Holt Harvey Plastic Pro | Drug administering coil-like device for insertion in body cavity of animal |
| US5007790A (en) | 1989-04-11 | 1991-04-16 | Depomed Systems, Inc. | Sustained-release oral drug dosage form |
| NZ234227A (en) | 1989-06-30 | 1991-08-27 | Smithkline Beecham Corp | Delayed release dosage form |
| JPH03163011A (ja) * | 1989-08-31 | 1991-07-15 | Yamanouchi Pharmaceut Co Ltd | 胃内滞留デバイス |
| US5047464A (en) | 1989-09-20 | 1991-09-10 | Merck & Co., Inc. | Bioerodible thermoset elastomers |
| US5121329A (en) | 1989-10-30 | 1992-06-09 | Stratasys, Inc. | Apparatus and method for creating three-dimensional objects |
| JP2648897B2 (ja) | 1991-07-01 | 1997-09-03 | 塩野義製薬株式会社 | ピリミジン誘導体 |
| US5939467A (en) | 1992-06-26 | 1999-08-17 | The Procter & Gamble Company | Biodegradable polymeric compositions and products thereof |
| US5369142A (en) | 1993-01-15 | 1994-11-29 | The Ohio State University | Water soluble polymers containing amino acid residues for dental restoratives |
| WO1995003558A1 (en) | 1993-07-19 | 1995-02-02 | Reflexite Corporation | Retroreflective structure |
| DE4406424A1 (de) | 1994-02-28 | 1995-08-31 | Bayer Ag | Expandierbare Arzneiformen |
| US5837276A (en) | 1994-09-02 | 1998-11-17 | Delab | Apparatus for the delivery of elongate solid drug compositions |
| US6436069B1 (en) | 1995-03-23 | 2002-08-20 | Advanced Animal Technology Limited | Substance delivery device |
| US6962579B2 (en) | 1995-03-23 | 2005-11-08 | Advanced Animal Technology Limited | Substance delivery device |
| DE19539361A1 (de) | 1995-10-23 | 1997-04-24 | Basf Ag | Verfahren zur Herstellung von mehrschichtigen, festen Arzneiformen zur oralen oder rektalen Verabreichung |
| US5840332A (en) | 1996-01-18 | 1998-11-24 | Perio Products Ltd. | Gastrointestinal drug delivery system |
| AU2521797A (en) | 1996-04-12 | 1997-11-07 | Japan Atomic Energy Research Institute | Ph-sensitive polymers |
| US5762637A (en) * | 1996-08-27 | 1998-06-09 | Scimed Life Systems, Inc. | Insert molded catheter tip |
| US6120803A (en) | 1997-08-11 | 2000-09-19 | Alza Corporation | Prolonged release active agent dosage form adapted for gastric retention |
| DE19850309A1 (de) | 1998-10-30 | 2000-05-04 | Lohmann Therapie Syst Lts | Expandierbares gastroretensives Therapiesystem mit verlängerter Magenverweildauer |
| IL133196A0 (en) | 1999-11-29 | 2001-03-19 | Yissum Res Dev Co | Gastroretentive controlled release pharmaceutical dosage forms |
| GB0001621D0 (en) | 2000-01-26 | 2000-03-15 | Astrazeneca Ab | Pharmaceutical compositions |
| CA2408956C (en) | 2000-05-18 | 2011-07-12 | Therics, Inc. | Method and form of a drug delivery device,such as encapsulating a toxic core within a non-toxic region in an oral dosage form |
| WO2001091553A1 (en) * | 2000-05-26 | 2001-12-06 | Demegen, Inc. | Composite wafer for controlled drug delivery |
| US6488962B1 (en) | 2000-06-20 | 2002-12-03 | Depomed, Inc. | Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms |
| US8158143B2 (en) | 2000-07-14 | 2012-04-17 | Helmholtz-Zentrum Geesthacht Zentrum Fuer Material- Und Kuestenforschung Gmbh | Systems for releasing active ingredients, based on biodegradable or biocompatible polymers with a shape memory effect |
| US7803392B2 (en) | 2000-12-27 | 2010-09-28 | University Of Kentucky Research Foundation | pH-Sensitive mucoadhesive film-forming gels and wax-film composites suitable for topical and mucosal delivery of molecules |
| US6627206B2 (en) | 2001-07-25 | 2003-09-30 | Greg A. Lloyd | Method and apparatus for treating obesity and for delivering time-released medicaments |
| CN1543337A (zh) | 2001-08-16 | 2004-11-03 | ���ո����ɸߵȽ�����ίԱ�������� | 可膨胀的胃潴留装置 |
| US20040219186A1 (en) | 2001-08-16 | 2004-11-04 | Ayres James W. | Expandable gastric retention device |
| EP1503717A1 (en) | 2002-01-23 | 2005-02-09 | The UAB Research Foundation | Glass-ionomer cements containing amino acids |
| WO2003089506A1 (en) | 2002-04-22 | 2003-10-30 | Purdue Research Foundation | Hydrogels having enhanced elasticity and mechanical strength properties |
| DE10224352A1 (de) | 2002-06-01 | 2003-12-11 | Mueller Schulte Detlef | Thermosensitive Polymerträger mit veränderbarer physikalischer Struktur für die biochemische Analytik, Diagnostik und Therapie |
| GB0214013D0 (en) | 2002-06-18 | 2002-07-31 | Euro Celtique Sa | Pharmaceutical product |
| TWI336260B (en) | 2002-07-25 | 2011-01-21 | Glaxo Group Ltd | Dosage form suitable for retaining drug substance |
| EP1560569A4 (en) | 2002-10-11 | 2006-03-22 | Depomed Dev Ltd | GASTRORETENTIVE LEVODOPA DELIVERY FORM |
| EP1594475A1 (en) | 2003-02-19 | 2005-11-16 | Mnemoscience GmbH | Self-expanding device for the gastrointestinal or urogenital area |
| JP4497833B2 (ja) | 2003-04-21 | 2010-07-07 | 富士フイルム株式会社 | ポジ型平版印刷版原版 |
| US7662864B2 (en) | 2003-06-04 | 2010-02-16 | Rutgers, The State University Of New Jersey | Solution polymerization processes to prepare a polymer that degrades to release a physiologically active agent |
| WO2004110313A1 (de) | 2003-06-13 | 2004-12-23 | Mnemoscience Gmbh | Stents |
| WO2004112755A1 (en) | 2003-06-18 | 2004-12-29 | John Michael Newton | Controlled release devices with lumens |
| US20090259236A2 (en) | 2003-07-28 | 2009-10-15 | Baronova, Inc. | Gastric retaining devices and methods |
| US8048169B2 (en) | 2003-07-28 | 2011-11-01 | Baronova, Inc. | Pyloric valve obstructing devices and methods |
| DE10350556A1 (de) | 2003-10-29 | 2005-06-02 | Clariant Gmbh | Wasserbasierende Pigmentpräparationen |
| US6825308B1 (en) | 2003-10-29 | 2004-11-30 | Council Of Scientific And Industrial Research | Copolymers and preparation thereof |
| CA2549195A1 (en) | 2003-12-09 | 2005-06-23 | Spherics, Inc. | Bioadhesive polymers with catechol functionality |
| US20050163858A1 (en) | 2003-12-31 | 2005-07-28 | Garth Boehm | Ziprasidone formulations |
| US20080089933A1 (en) | 2006-10-16 | 2008-04-17 | Amir Alon | Device and method for reducing calorie intake |
| TW200539903A (en) | 2004-03-12 | 2005-12-16 | Smithkline Beecham Plc | Pharmaceutical formulations |
| US7964196B2 (en) | 2004-05-25 | 2011-06-21 | Chimeros, Inc. | Self-assembling nanoparticle drug delivery system |
| DE102004047076A1 (de) | 2004-09-28 | 2006-04-06 | Zimmer Ag | Verfahren zur Herstellung von Polyestern |
| IL166183A0 (en) | 2005-01-06 | 2006-01-15 | Yissum Res Dev Co | Novel diagnostic and imaging techniques of the gi tract |
| AU2006209239A1 (en) | 2005-01-27 | 2006-08-03 | A.V. Topchiev Institute Of Petrochemical Synthesis | Hydrophilic biocompatible adhesive formulations and uses |
| WO2006084164A2 (en) | 2005-02-01 | 2006-08-10 | Emisphere Technologies, Inc. | Gastric retention and controlled release delivery system |
| US7785291B2 (en) * | 2005-03-01 | 2010-08-31 | Tulip Medical Ltd. | Bioerodible self-deployable intragastric implants |
| JP2006323082A (ja) | 2005-05-18 | 2006-11-30 | Canon Inc | 現像剤補給容器 |
| US8021384B2 (en) * | 2005-07-26 | 2011-09-20 | Ram Weiss | Extending intrabody capsule |
| CN101175571A (zh) | 2005-08-05 | 2008-05-07 | 滋贺县 | 含有共混聚合物而成的液体中物质转移材料 |
| US20070048383A1 (en) | 2005-08-25 | 2007-03-01 | Helmus Michael N | Self-assembled endovascular structures |
| WO2007048223A2 (en) | 2005-10-25 | 2007-05-03 | Pharmascience Inc. | A gastric retention drug delivery system |
| EP1945189A4 (en) | 2005-11-03 | 2012-08-15 | Sun Pharmaceutical Ind Ltd | CONTROLLED RELEASE COATED TABLETS CHARACTERIZED BY PROLONGED GASTRIC RETENTION |
| US7674396B2 (en) | 2005-11-08 | 2010-03-09 | Plensat Llc | Method and system for treatment of eating disorders |
| PL1981465T3 (pl) | 2006-01-18 | 2016-03-31 | Intec Pharma Ltd | Metoda wytwarzania przyrządów do podawania środka przyjmowanego doustnie |
| CA2642479C (en) | 2006-02-15 | 2014-08-19 | Intec Pharma Ltd. | A gastro-retentive system for the delivery of macromolecules |
| EP1998684A4 (en) | 2006-03-10 | 2014-09-17 | Massachusetts Inst Technology | CONJUGATES AND NANOSYSTEMS WITH TRIGGERED SELF ASSEMBLY |
| US7691151B2 (en) | 2006-03-31 | 2010-04-06 | Spiration, Inc. | Articulable Anchor |
| US20070264307A1 (en) | 2006-05-15 | 2007-11-15 | Medtronic Vascular, Inc. | Biodegradable Modified Caprolactone Polymers for Fabricating and Coating Medical Devices |
| EP1886665A1 (en) | 2006-08-01 | 2008-02-13 | Boehringer Ingelheim Pharma GmbH & Co. KG | Gastro retentive delivery system |
| RU2420268C2 (ru) | 2006-09-04 | 2011-06-10 | Панацея Биотек Лимитед | Способ программируемой плавучей доставки |
| US20080075766A1 (en) | 2006-09-25 | 2008-03-27 | Shun-Por Li | Multi-core dosage form having transparent outer coating |
| WO2008079404A2 (en) | 2006-12-22 | 2008-07-03 | Combinatorx, Incorporated | Pharmaceutical compositions for treatment of parkinson's disease and related disorders |
| US20100297009A1 (en) | 2007-03-13 | 2010-11-25 | Technion Research & Development Foundation Ltd. | Self-assembled polyhedral multimeric chemical structures |
| WO2008140651A2 (en) | 2007-03-13 | 2008-11-20 | Olson Arthur J | Self-assembled polyhedra |
| WO2008124122A1 (en) | 2007-04-09 | 2008-10-16 | Scidose, Llc | Combinations of statins and anti-obesity agent and glitazones |
| EP2152315B1 (en) | 2007-05-25 | 2016-01-06 | Indivior UK Limited | Sustained delivery formulations of risperidone compounds |
| EP2155110B1 (en) | 2007-05-25 | 2017-01-04 | Gorham Enterprises Llc | Bariatric magnetic apparatus and method of manufacturing thereof |
| US8038659B2 (en) | 2007-10-17 | 2011-10-18 | The Invention Science Fund I, Llc | Disintegrating digestive tract interaction system |
| US8637455B2 (en) | 2007-10-22 | 2014-01-28 | Affinergy, Llc | Compositions and methods for delivery of glycopeptide antibiotics to medical device surfaces |
| US8974814B2 (en) | 2007-11-12 | 2015-03-10 | California Institute Of Technology | Layered drug delivery polymer monofilament fibers |
| WO2009114118A2 (en) | 2008-03-08 | 2009-09-17 | Theraquest Biosciences, Inc. | Oral pharmaceutical compositions of buprenorphine and method of use |
| CA2720108C (en) | 2008-03-11 | 2016-06-07 | Depomed, Inc. | Gastric retentive extended-release dosage forms comprising combinations of a non-opioid analgesic and an opioid analgesic |
| US20130273135A1 (en) | 2008-03-25 | 2013-10-17 | University Of Utah Research Foundation | Controlled Release Combination Biomaterials |
| CA2721493C (en) | 2008-04-18 | 2017-11-28 | Intec Pharma Ltd. | Carbidopa/levodopa gastroretentive drug delivery |
| WO2009132461A1 (en) | 2008-04-28 | 2009-11-05 | Electronic Dietary Foods Inc. | Bezoar-forming units for weight control |
| US20100256342A1 (en) | 2008-08-12 | 2010-10-07 | Francis Raymond Salemme | Protein nodes for controlled nanoscale assembly |
| EP2329810A4 (en) | 2008-08-18 | 2012-09-19 | Team Academy Of Pharmaceutical Science | DRUG DISPENSING SYSTEM WITH MAGNETIC RETENTION, MANUFACTURING PROCESS AND APPLICATION |
| US20110268666A1 (en) | 2008-09-29 | 2011-11-03 | Yissum Research Development Company of the Research University of Jerusalem, Ltd. | Novel gastroretentive delivery system |
| EP2331014B1 (en) | 2008-10-10 | 2017-08-09 | Reva Medical, Inc. | Expandable slide and lock stent |
| JP2012510987A (ja) | 2008-12-04 | 2012-05-17 | インテック ファーマ リミテッド | ザレプロン胃内滞留性薬剤送達システム |
| WO2010074712A2 (en) | 2008-12-27 | 2010-07-01 | Duggirala Chandra S | Devices for treating obesity and methods of using those devices |
| CN102414116B (zh) | 2009-02-26 | 2015-01-21 | 加利福尼亚大学董事会 | 用于制备尺寸可控的纳米颗粒的超分子方法 |
| US8414559B2 (en) | 2009-05-07 | 2013-04-09 | Rainbow Medical Ltd. | Gastroretentive duodenal pill |
| WO2010132648A1 (en) * | 2009-05-15 | 2010-11-18 | Intersect Ent, Inc. | Expandable devices and methods therefor |
| DE102009028076A1 (de) | 2009-07-29 | 2011-02-03 | Evonik Röhm Gmbh | Beschichtungsmittel zum Tauchbeschichten von Kapselhälften |
| US20110052700A1 (en) | 2009-08-31 | 2011-03-03 | Depomed, Inc. | Gastric retentive pharmaceutical compositions for immediate and extended release of levosulpiride |
| WO2011032087A2 (en) | 2009-09-11 | 2011-03-17 | Replication Medical Inc. | Swellable polymeric device for dietary regulation |
| EP2490677A2 (en) | 2009-10-19 | 2012-08-29 | Intec Pharma Ltd. | Novel gastroretentive dosage forms of poorly soluble drugs |
| US9421169B2 (en) | 2009-11-20 | 2016-08-23 | Covidien Lp | Oral dosage forms for delivery of therapeutic agents |
| CN101711752B (zh) | 2009-11-26 | 2011-09-21 | 中国科学院上海药物研究所 | 一种苯并异噁唑类衍生物的控释制剂及其制备方法 |
| US11535510B2 (en) | 2010-04-27 | 2022-12-27 | The Johns Hopkins University | Self-folding sub-centimeter structures |
| BR112013000190A2 (pt) | 2010-07-06 | 2017-11-07 | Gruenenthal Gmbh | formas de dosagem de retenção gástrica compreendendo um análogo de gaba e um opioide |
| ES2729782T3 (es) * | 2010-08-05 | 2019-11-06 | Taris Biomedical Llc | Dispositivos implantables de administración de fármacos para sitios urogenitales |
| US20120165793A1 (en) | 2010-12-22 | 2012-06-28 | Ethicon Endo-Surgery, Inc. | Pill Catchers |
| US20120165792A1 (en) | 2010-12-22 | 2012-06-28 | Ethicon Endo-Surgery, Inc. | Pill Catchers |
| US20120165794A1 (en) | 2010-12-22 | 2012-06-28 | Ethicon Endo-Surgery, Inc. | Pill Catchers |
| KR20140048086A (ko) | 2011-02-04 | 2014-04-23 | 타리스 바이오메디컬 인코포레이티드 | 저 용해성 약물의 제어 방출을 위한 이식가능한 디바이스 |
| US20130017264A1 (en) | 2011-07-15 | 2013-01-17 | Piramal Life Sciences Limited | Alginate tube drug delivery system and method therefor |
| WO2013049188A1 (en) | 2011-09-26 | 2013-04-04 | Northeastern University | Customizable embedded sensors |
| US20150265536A1 (en) | 2011-12-09 | 2015-09-24 | Purdue Pharma L.P. | Pharmaceutical dosage forms comprising poly(epsilon-caprolactone) and polyethylene oxide |
| US8979885B2 (en) | 2012-02-24 | 2015-03-17 | Elwha Llc | Devices, systems, and methods to control stomach volume |
| CA3149459A1 (en) | 2012-07-16 | 2014-01-23 | APET Holding B.V. | Gastro-retentive drug delivery system |
| US9307966B2 (en) * | 2012-08-15 | 2016-04-12 | St. Jude Medical Puerto Rico Llc | Vascular closure device anchor |
| RU2015107517A (ru) | 2012-08-16 | 2016-10-10 | Тева Фармасьютикал Индастриес Лтд. | Фармацевтические композиции мемантина |
| US10441760B2 (en) | 2013-03-01 | 2019-10-15 | The Johns Hopkins University | Self-actuating chemomechanical devices for delivery and extended release of therapeutic agents in the gastrointestinal tract |
| CN103654903A (zh) | 2013-11-27 | 2014-03-26 | 西安交通大学 | 一种用于人体消化道吻合的磁性可降解装置 |
| US11129793B2 (en) | 2013-12-05 | 2021-09-28 | Epitomee Medical Ltd | Retentive devices and systems for in-situ release of pharmaceutical active agents |
| US20170051099A1 (en) | 2014-04-29 | 2017-02-23 | The Brigham And Women's Hospital, Inc. | Polymeric materials for bio-applications |
| CN106456550A (zh) | 2014-05-26 | 2017-02-22 | 格吕伦塔尔有限公司 | 避免乙醇剂量倾泻的多颗粒 |
| BR112016028180A2 (pt) | 2014-06-02 | 2017-08-22 | Teva Pharma | forma de dosagem gastrorretentiva expansível |
| US20170266112A1 (en) | 2014-06-11 | 2017-09-21 | Massachusetts Institute Of Technology | Residence structures and related methods |
| DK3155024T4 (da) | 2014-06-11 | 2025-07-21 | Massachusetts Inst Technology | Opholdsstrukturer og relaterede fremgangsmåder |
| US10953208B2 (en) | 2015-05-01 | 2021-03-23 | Massachusetts Institute Of Technology | Triggerable shape memory induction devices |
| AU2016342374B2 (en) | 2015-10-23 | 2022-08-04 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained release of therapeutic agents and methods of use thereof |
| JP2018536007A (ja) | 2015-12-01 | 2018-12-06 | クレキシオ バイオサイエンシーズ エルティーディー． | 胃保持性装置 |
| JP2018537201A (ja) | 2015-12-02 | 2018-12-20 | クレキシオ バイオサイエンシーズ エルティーディー． | 胃保持型投与形態を調整する装置および方法 |
| US11992552B2 (en) | 2015-12-08 | 2024-05-28 | Lyndra Therapeutics, Inc. | Geometric configurations for gastric residence systems |
| EP3246050A1 (de) | 2016-05-17 | 2017-11-22 | BSN medical GmbH | Wund- oder hautauflage |
| EP3463313A4 (en) | 2016-05-27 | 2019-12-18 | Lyndra, Inc. | MATERIAL ARCHITECTURE FOR STOMACH DWELLING SYSTEMS |
| AU2017336154B2 (en) | 2016-09-30 | 2023-11-09 | Lyndra Therapeutics, Inc. | Gastric residence systems for sustained delivery of adamantane-class drugs |
| US20200230244A1 (en) | 2016-11-09 | 2020-07-23 | Massachusetts Institute Of Technology | Triggerable hydrogel compositions and related methods |
| IL266377B2 (en) | 2016-12-02 | 2023-10-01 | Clexio Biosciences Ltd | Gastric residence system |
| WO2018227147A1 (en) | 2017-06-09 | 2018-12-13 | Lyndra, Inc. | Gastric residence systems with release rate-modulating films |
| JP7288435B2 (ja) | 2017-09-20 | 2023-06-07 | リンドラ セラピューティクス， インコーポレイティド | 胃内滞留システムのカプセル封入 |
| US11547839B2 (en) | 2017-12-04 | 2023-01-10 | Clexio Biosciences Ltd. | Long acting gastric residence system |
| WO2019232292A1 (en) | 2018-05-31 | 2019-12-05 | Massachusetts Institute Of Technology | Resident articles for gram-level dosing |
| WO2020102650A2 (en) | 2018-11-15 | 2020-05-22 | Massachusetts Institute Of Technology | Thermally controlled reconfigurable medical devices |
-
2016
- 2016-12-07 US US15/782,021 patent/US11992552B2/en active Active
- 2016-12-07 KR KR1020187019485A patent/KR102796240B1/ko active Active
- 2016-12-07 EP EP23194235.0A patent/EP4302817A3/en active Pending
- 2016-12-07 CA CA3007633A patent/CA3007633A1/en active Pending
- 2016-12-07 JP JP2018529233A patent/JP7030052B2/ja active Active
- 2016-12-07 MX MX2018006912A patent/MX2018006912A/es unknown
- 2016-12-07 AU AU2016366192A patent/AU2016366192B2/en active Active
- 2016-12-07 SG SG11201804384UA patent/SG11201804384UA/en unknown
- 2016-12-07 BR BR112018011636-0A patent/BR112018011636B1/pt active IP Right Grant
- 2016-12-07 CN CN202510879563.0A patent/CN120827528A/zh active Pending
- 2016-12-07 WO PCT/US2016/065453 patent/WO2017100367A1/en not_active Ceased
- 2016-12-07 ES ES16873798T patent/ES2963058T3/es active Active
- 2016-12-07 EP EP16873798.9A patent/EP3386488B1/en active Active
- 2016-12-07 CN CN201680081222.8A patent/CN108697649A/zh active Pending
-
2018
- 2018-06-05 IL IL259838A patent/IL259838B2/en unknown
-
2024
- 2024-04-16 US US18/637,281 patent/US20240342081A1/en active Pending
- 2024-09-20 ZA ZA2024/07197A patent/ZA202407197B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| IL259838B2 (en) | 2023-02-01 |
| AU2016366192B2 (en) | 2022-08-04 |
| MX2018006912A (es) | 2018-08-16 |
| WO2017100367A1 (en) | 2017-06-15 |
| EP4302817A2 (en) | 2024-01-10 |
| US20240342081A1 (en) | 2024-10-17 |
| NZ743506A (en) | 2024-07-26 |
| JP2019503347A (ja) | 2019-02-07 |
| CA3007633A1 (en) | 2017-06-15 |
| IL259838B (en) | 2022-10-01 |
| EP3386488A1 (en) | 2018-10-17 |
| IL259838A (en) | 2018-07-31 |
| ZA202407197B (en) | 2025-06-25 |
| RU2018124706A (ru) | 2020-01-14 |
| US20190262265A1 (en) | 2019-08-29 |
| HK1259225A1 (en) | 2019-11-29 |
| BR112018011636A2 (pt) | 2018-11-27 |
| ES2963058T3 (es) | 2024-03-25 |
| AU2016366192A1 (en) | 2018-07-05 |
| EP4302817A3 (en) | 2024-02-21 |
| KR102796240B1 (ko) | 2025-04-16 |
| EP3386488A4 (en) | 2019-08-07 |
| EP3386488B1 (en) | 2023-09-06 |
| US11992552B2 (en) | 2024-05-28 |
| JP7030052B2 (ja) | 2022-03-04 |
| CN108697649A (zh) | 2018-10-23 |
| KR20180090881A (ko) | 2018-08-13 |
| CN120827528A (zh) | 2025-10-24 |
| RU2018124706A3 (enExample) | 2020-06-08 |
| BR112018011636B1 (pt) | 2024-03-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SG11201804384UA (en) | Geometric configurations for gastric residence systems | |
| SG11201908532UA (en) | Macrocyclic compounds as ros1 kinase inhibitors | |
| SG11201908330PA (en) | Farnesoid x receptor agonists and uses thereof | |
| SG11201906891RA (en) | Methods for the administration of certain vmat2 inhibitors | |
| SG11201805072PA (en) | Nicotine powder delivery system | |
| SG11201910101SA (en) | Alphavirus neoantigen vectors | |
| SG11201809344QA (en) | Process for synthesizing 2-hydroxy-6-((2-(1-isopropyl-1h-pyrazol-5-yl)-pyridin-3-yl)methoxy)benzaldehyde | |
| SG11201804443UA (en) | Antisense oligomers for treatment of autosomal dominant mental retardation-5 and dravet syndrome | |
| SG11201808125RA (en) | Methods for solid tumor treatment | |
| SG11201804098TA (en) | Purinones as ubiquitin-specific protease 1 inhibitors | |
| SG11201808990QA (en) | Compositions for topical application of compounds | |
| SG11201804934PA (en) | Novel Compounds | |
| SG11201809499UA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| SG11201809908TA (en) | Stabilized glycopeptide antibiotic formulations | |
| SG11201804263PA (en) | Cancer treatment using 2-deoxy-2-fluoro-l-fucose in combination with a checkpoint inhibitor | |
| SG11201900558RA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201900132QA (en) | Selecting neoepitopes as disease-specific targets for therapy with enhanced efficacy | |
| SG11201900551WA (en) | Spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201811221XA (en) | Imidazo[1,2-a]pyridine derivatives, methods for preparing the same and use thereof | |
| SG11201808676RA (en) | Methods of treating pediatric cancers | |
| SG11201903431SA (en) | Sstr-targeted conjugates and particles and formulations thereof | |
| SG11201900546UA (en) | Spiro-lactam and bis-spiro-lactam nmda receptor modulators and uses thereof | |
| SG11201806623VA (en) | Bacteria over-expressing c-di-amp and therapeutic methods | |
| SG11201809497RA (en) | Processes for preparing phosphorodiamidate morpholino oligomers | |
| SG11201810853UA (en) | Anti-tnfrsf25 antibodies |